Page last updated: 2024-08-21

pyrazines and Dermatoses

pyrazines has been researched along with Dermatoses in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hata, T; Li, C; Two, AM1
Abe, Y; Honda, Y; Iki, S; Inoue, J; Miyazaki, K; Sekine, E; Shingaki, S; Suzuki, K; Tsukada, N1
Abedi, M; Blazar, BR; Chen, M; Hagino, T; Hsiao, HH; Mall, C; Monjazeb, A; Murphy, WJ; Pai, CC; Sun, K; Tellez, J1
Andreoli, A; Briere, J; Cavelier Balloy, B; Petit, A; Thomas, M1
Avenel-Audran, M; Croué, A; Dib, M; Hunault-Berger, M; Lissandre, S; Moles, MP; Tanguy-Schmidt, A; Zidane-Marinnes, M1
Denda, M; Denda, S; Tsutsumi, M1
Cahu, X; Dauriac, C; Houot, R; Lamy, T; Marchand, T; Tas, P1
Andreesen, R; Grube, M; Hafner, C; Hart, C; Wurm, S1
Burnett, CT; Santoro, FA1
Scheinfeld, N1

Reviews

1 review(s) available for pyrazines and Dermatoses

ArticleYear
A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine.
    Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzoates; Boronic Acids; Bortezomib; Cyclosporine; Dasatinib; Deferasirox; Humans; Iron Chelating Agents; Ophthalmic Solutions; Protein Kinase Inhibitors; Pyrazines; Pyrimidines; Randomized Controlled Trials as Topic; Skin Diseases; Skin Neoplasms; Thiazoles; Triazoles

2007

Other Studies

9 other study(ies) available for pyrazines and Dermatoses

ArticleYear
A case of eosinophilic dermatosis of hematologic malignancy in a patient with multiple myeloma.
    Dermatology online journal, 2014, Jan-15, Volume: 20, Issue:1

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Dexamethasone; Diagnosis, Differential; Eosinophilia; Herpes Simplex; Herpes Zoster; Humans; Insect Bites and Stings; Male; Middle Aged; Multiple Myeloma; Oligopeptides; Paraneoplastic Syndromes; Pemphigoid, Bullous; Pyrazines; Skin Diseases

2014
Effective control of skin reaction by air sandwich technique in a patient with IgE-κ myeloma treated with subcutaneous bortezomib injection.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:5

    Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Humans; Immunoglobulin E; Injections, Subcutaneous; Male; Middle Aged; Multiple Myeloma; Pyrazines; Skin Diseases; Treatment Outcome

2014
Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:12

    Topics: Acute Disease; Animals; Antibodies, Neutralizing; Antineoplastic Agents; Boronic Acids; Bortezomib; CD8-Positive T-Lymphocytes; Disease Models, Animal; Female; Graft vs Host Disease; Interleukin-6; Liver Diseases; Mice; Organ Specificity; Pyrazines; Skin Diseases

2014
[Bortezomib-induced neutrophilic dermatosis with CD30+ lymphocytic infiltration].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:5

    Topics: Antigens, CD; Antineoplastic Agents; Boronic Acids; Bortezomib; Exanthema; Female; Humans; Ki-1 Antigen; Lymphocytes; Middle Aged; Multiple Myeloma; Neoplasm Staging; Pyrazines; Skin Diseases

2009
[Bortezomib-induced acute neutrophilic dermatosis].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:5

    Topics: Aged; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Humans; Male; Multiple Myeloma; Neutrophils; Pyrazines; Skin Diseases; Sweet Syndrome

2009
Topical application of TRPM8 agonists accelerates skin permeability barrier recovery and reduces epidermal proliferation induced by barrier insult: role of cold-sensitive TRP receptors in epidermal permeability barrier homoeostasis.
    Experimental dermatology, 2010, Volume: 19, Issue:9

    Topics: Administration, Cutaneous; Anilides; Animals; Cells, Cultured; Epidermis; Homeostasis; Humans; Hyperplasia; Keratinocytes; Male; Menthol; Mice; Mice, Hairless; Permeability; Pyrazines; Pyridines; Ruthenium Red; Skin Diseases; TRPM Cation Channels

2010
Cutaneous macroglobulinosis treated with bortezomib and rituximab.
    European journal of haematology, 2011, Volume: 87, Issue:1

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Boronic Acids; Bortezomib; Humans; Immunoglobulin M; Male; Pyrazines; Recurrence; Rituximab; Skin Diseases; Waldenstrom Macroglobulinemia

2011
[Unusual skin alterations in a 72-year-old patient with multiple myeloma].
    Der Internist, 2012, Volume: 53, Issue:4

    Topics: Aged; Amyloidosis; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Dexamethasone; Diagnosis, Differential; Female; Humans; Multiple Myeloma; Pyrazines; Skin Diseases; Treatment Outcome

2012
Extramedullary plasmacytomas presenting as asymptomatic nodules on the buttocks and thighs.
    Journal of drugs in dermatology : JDD, 2012, Volume: 11, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Buttocks; Dexamethasone; Humans; Middle Aged; Multimodal Imaging; Multiple Myeloma; Positron-Emission Tomography; Pyrazines; Skin Diseases; Thigh; Tomography, X-Ray Computed

2012